Arcus Biosciences Inc (RCUS)

Arcus Biosciences Inc (RCUS) is a Biotechnology company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $2.8B; returns 1 day -4.2%, 1 week -16.2%, 1 year +10.5%.

Arcus Biosciences Inc. is a clinical-stage global biopharmaceutical company primarily focused on the discovery and development of differentiated molecules and combination therapies for cancer, with an emerging focus on inflammatory and autoimmune diseases.

Groups RCUS belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Oncology
• Cancer Therapeutics
• Immunotherapy
• Drug Discovery
• Healthcare
• Clinical Stage
• Monoclonal Antibodies
• Strategic Partnerships
• Life Sciences

RCUS financial model: income statement, cash flow and balance sheet